You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AT-1501

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Transplant Rejection Trial in Montréal (AT-1501, Tacrolimus)

Enrolling by invitation
  • Kidney Transplant Rejection
  • Montréal, Quebec, Canada
    McGill University Health Care Centre
Nov 6, 2023

Kidney Transplant Rejection Trial in Saint Louis, Richmond (AT-1501, Tacrolimus)

Recruiting
  • Kidney Transplant Rejection
  • Saint Louis, Missouri
  • +1 more
Aug 2, 2023

Brittle Type 1 Diabetes Trial (AT-1501 IV Infusion, Isolated cadaveric islet cells)

Not yet recruiting
  • Brittle Type 1 Diabetes Mellitus
  • AT-1501 IV Infusion
  • Isolated cadaveric islet cells
  • (no location specified)
Jul 27, 2022

Kidney Transplant Trial in Montréal (AT-1501)

Recruiting
  • Kidney Transplant
  • AT-1501
  • Montréal, Quebec, Canada
    McGill University Health Care Centre
May 16, 2022

IgA Nephropathy, IgAN Trial in Worldwide (AT-1501)

Recruiting
  • IgA Nephropathy
  • IgAN
  • AT-1501
  • Liverpool, South Wales, Australia
  • +23 more
Dec 5, 2022

Type 1 Diabetes Trial in Edmonton (AT-1501)

Recruiting
  • Type 1 Diabetes Mellitus
  • AT-1501
  • Edmonton, Alberta, Canada
    University of Alberta
Sep 2, 2021

Child Wellbeing, Adolescent Health, Quality of Life Trial in Moss (5Ways@School)

Enrolling by invitation
  • Child Wellbeing
  • +2 more
  • 5Ways@School
  • Moss, Norway
    Kristian Green Krogshus
Nov 22, 2023

COVID-19 Trial in Worldwide (Sotrovimab)

Recruiting
  • COVID-19
  • Sotrovimab
  • Cullman, Alabama
  • +17 more
Nov 4, 2022

Glycogen Storage Disease Trial in United States (mRNA-3745)

Recruiting
  • Glycogen Storage Disease
  • Farmington, Connecticut
  • +4 more
Jun 10, 2022

Acute GVHD Trial in United States (Sirolimus, Prednisone)

Completed
Has Results
  • Acute GVHD
  • Duarte, California
  • +20 more
Oct 20, 2021

Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)

Not yet recruiting
  • Diffuse Glioma
  • Malignant Glioma
  • Biospecimen Collection
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 6, 2023

High-risk NMIBC Trial (SHR-1501)

Recruiting
  • High-risk NMIBC
  • Beijing, Beijing, China
    Peking University First Hospital
Nov 28, 2022

Bladder Cancer Trial in Melbourne (APL-1202 and APL-1501 (Single ascending dose), APL-1202 and APL-1501 (Multiple Ascending

Not yet recruiting
  • Bladder Cancer
  • APL-1202 and APL-1501 (Single ascending dose)
  • APL-1202 and APL-1501 (Multiple Ascending dose)
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd
Sep 11, 2023

Postoperative Pain Trial in Japan (SyB P-1501, SyB P-1501 )

Terminated
  • Postoperative Pain
  • SyB P-1501
  • SyB P-1501 placebo
  • Nagakute, Aichi, Japan
  • +28 more
Nov 14, 2022

Cancer, Solid Tumor, Solid Carcinoma Trial in United States (AMXT1501, DFMO)

Active, not recruiting
  • Cancer
  • +3 more
  • Austin, Texas
  • +3 more
Jan 18, 2023

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

High-grade Serous Ovarian Carcinoma, Ovarian Carcinoma Trial in Worldwide (Pembrolizumab, Paclitaxel, Carboplatin)

Recruiting
  • High-grade Serous Ovarian Carcinoma
  • Ovarian Carcinoma
  • Pembrolizumab
  • +5 more
  • Aurora, Colorado
  • +37 more
Jan 19, 2023

Lymphoblastic Leukemia, Acute Adult Trial in Japan (TBI-1501)

Active, not recruiting
  • Lymphoblastic Leukemia, Acute Adult
  • TBI-1501
  • Yoshida, Fukui, Japan
  • +10 more
Jun 15, 2022

Non-Segmental Vitiligo Trial in Worldwide (Upadacitinib, Placebo)

Active, not recruiting
  • Non-Segmental Vitiligo
  • Irvine, California
  • +34 more
Jan 31, 2023

Trigeminal Neuralgia Trial in Birmingham (Unframed Virtual Cone, 80 Gy Radiation)

Recruiting
  • Trigeminal Neuralgia
  • Unframed Virtual Cone
  • 80 Gy Radiation
  • Birmingham, Alabama
    Hazelrig-Salter Radiation Oncology Center
Sep 12, 2022

Axial Spondyloarthritis Trial in Beijing (GR1501 low dose, GR1501 high dose, )

Active, not recruiting
  • Axial Spondyloarthritis
  • GR1501 low dose
  • +2 more
  • Beijing, Beijing, China
    Peking union Medical Hosipital
May 21, 2023

Chronic Kidney Disease With High Proteinuria Trial in Worldwide (Zibotentan/Dapagliflozin, Dapagliflozin)

Not yet recruiting
  • Chronic Kidney Disease With High Proteinuria
  • Bakersfield, California
  • +99 more
Oct 17, 2023

Relapsed or Refractory DLBCL Trial in Worldwide (MK-2140 (zilovertamab vedotin))

Recruiting
  • Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  • MK-2140 (zilovertamab vedotin)
  • Orange, California
  • +38 more
Aug 12, 2022

Carcinoma, Hepatocellular, Colorectal Tumors, Pancreatic Ductal Adenocarcinoma Trial in Worldwide (Pembrolizumab, Belzutifan,

Recruiting
  • Carcinoma, Hepatocellular
  • +5 more
  • Duarte, California
  • +39 more
Jul 29, 2022

Narcolepsy Type 1 (NT 1) Trial in Worldwide (TAK-994, Placebo)

Terminated
  • Narcolepsy Type 1 (NT 1)
  • Alabaster, Alabama
  • +69 more
Oct 5, 2022